© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma
Affiliation of authors: Department of Etiology and Carcinogenesis, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Correspondence to: Dongxin Lin, MD, Department of Etiology and Carcinogenesis, Cancer Institute, Chinese Academy of Medical Sciences, Beijing 100021, China (e-mail: dlin@public.bta.net.cn)
| The first 10% of the full text of this article appears below. |
Recently, we reported a statistically significant association between genetic polymorphisms in the death pathway genes FAS and FASL and risk of esophageal squamous-cell carcinoma among the Chinese (1). Krippl et al. now extend the results to breast cancer, showing a similar association between the FAS 1377G>A polymorphism and risk of the cancer among Caucasians. However,
Related Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2004 96: 1478-1479.
This article has been cited by other articles:
![]() |
T. Sun, Y. Zhou, H. Li, X. Han, Y. Shi, L. Wang, X. Miao, W. Tan, D. Zhao, X. Zhang, et al. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer J. Exp. Med., October 3, 2005; 202(7): 967 - 974. [Abstract] [Full Text] [PDF] |
||||
